Cargando…
miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
BACKGROUND: Pancreatic cancer is one of the most lethal human malignancies, with an all-stage 5-year survival of <5%, mainly due to lack of effective available therapies. Cancer cell survival is dependent upon up-regulation of the pro-survival response, mediated by anti-apoptotic proteins such as...
Autores principales: | Chen, Zhiyu, Sangwan, Veena, Banerjee, Sulagna, Mackenzie, Tiffany, Dudeja, Vikas, Li, Xiaowu, Wang, Huaizhi, Vickers, Selwyn M, Saluja, Ashok K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848798/ https://www.ncbi.nlm.nih.gov/pubmed/24025188 http://dx.doi.org/10.1186/1476-4598-12-105 |
Ejemplares similares
-
MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization
por: Banerjee, Sulagna, et al.
Publicado: (2012) -
Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019) -
Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019) -
Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015) -
CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)